Cell And Gene Therapy Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
The Business Research Company’s Cell And Gene Therapy Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
LONDON, GREATER LONDON, UK, October 18, 2022 /EINPresswire.com/ — As per The Business Research Company’s “Cell And Gene Therapy Global Market Report 2022”, the cell and gene therapy market is expected to grow from $6.58 billion in 2021 to $8.57 billion in 2022 at a compound annual growth rate (CAGR) of 30.2%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The gene and cell therapy market is expected to reach $21.33 billion in 2026 at a CAGR of 25.6%. Steady investment and consolidation in cell and gene therapies contributed to the growth of the cell and gene therapy (CGT) market.
Request a Sample now to gain a better understanding of cell and gene therapy market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp
Key Trends In The Cell And Gene Therapy Market
Chimeric antigen receptor (CAR) T-cell therapy is shaping the cell and gene therapy (CGT) market. CAR T-cell therapy is a combination of cell and gene therapy in which T cells are collected from the patient’s blood and are genetically engineered to produce modified receptors at their surface, known as chimeric antigen receptors. These modified T cells with special structures (receptors) are reinfused into the patient. Then, the modified receptors of T cell help in targeting the surface antigen of the cancer cell that ultimately results in the killing of tumor cells in patients.
Overview Of The Cell And Gene Therapy Market
The cell and gene therapy market consist of sales of cell and gene therapies by entities (organizations, sole traders and partnerships) that develop cell and gene therapies. Cell therapy refers to the transfer of intact, live cells that are originated from autologous or allogenic sources and gene therapy refers to the introduction, removal, or change in the genome for treating diseases. The market consists of revenue generated by the companies developing cell and gene therapy products by the sales of these products.
Learn more on the global cell and gene therapy market report at:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-global-market-report
Cell And Gene Therapy Global Market Report 2022 from TBRC covers the following information:
Market Size Data
• Forecast period: Historical and Future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Market Segmentation
• By Product: Cell Therapy, Gene Therapy
• By Application: Oncology, Dermatology, Musculoskeletal, Others
• By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Others
• By Geography: The global cell and gene therapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Major market players such as Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio, and Fibrocell Science.
Trends, opportunities, strategies and so much more.
Cell And Gene Therapy Global Market Report 2022 is one of The Business Research Company’s comprehensive reports that provides cell and gene therapy market overview. The market report analyzes cell and gene therapy market size, cell and gene therapy market growth drivers, cell and gene therapy market segmentation, cell and gene therapy market major players, cell and gene therapy market growth across geographies, and cell and gene therapy market competitors’ revenues and market positioning. The cell and gene therapy market research report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential.
Not what you were looking for? Go through similar reports by The Business Research Company:
Gene Editing Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Stem Cell/Cord Blood Banking Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report
Cell Based Assays Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
About The Business Research Company?
The Business Research Company has published over 3000 industry reports, covering over 3000 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Get In Touch With Us –
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
